Medium materiality6/10
Spyre Therapeutics price target lowered to $127 from $135 at Deutsche Bank
Why it may matterVerify against the original reporting
Upside implied by PT above current price.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Deutsche Bank lowers SYRE PT to $127; price $107.36.
- Deutsche Bank cuts SYRE PT to $127; price $107.36.
Key facts
- 01
Target: $127
- 02
Posted price: $107.36
- 03
Analyst firm: Deutsche Bank
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.